Chiome Bioscience Inc. announced consolidated earnings results for the nine months ended September 30, 2020. For the period, the company's reported Net Sales were JPY 312 million compared to JPY 282 million for the same period a year ago. Operating loss was JPY 1,080 million compared to JPY 1,169 million for the same period a year ago. Net loss was JPY 1,087 million compared to JPY1,170 million for the same period a year ago. Loss per share was JPY 31.33 compared to JPY 37.92 for the same period a year ago.